Interpace Biosciences (IDXG) Reports Q2 EPS of $0.48

Interpace Biosciences (OTC: IDXG) reported Q2 EPS of $0.48, Revenue for the quarter came in at $12 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy